ArticleAnnals of medicine and surgery (2012)2026

Iberdomide enters multiple myeloma care: A new CELMoD with deep responses but uncertain long-term benefit.

Basit Ali Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.